OUR STRENSIQ ROUTINE
Quinn and I have our STRENSIQ routine. He retrieves the vials while I prepare syringes and supplies. Depending upon the site, either he or I do the injection.”
Kara, Caregiver HPP STAR
KARA, CAREGIVER HPP STAR AND
QUINN, WHO
LIVES WITH HPP
STRENSIQ® (asfotase alfa) is an injection given under the skin (called a subcutaneous injection) and can be conveniently taken at home or wherever you go.
STRENSIQ is dosed in milligrams based on weight. You and your doctor will decide which dosage and treatment schedule are right for you. As your weight changes, your dosage may also change depending on your doctor’s recommendations.
STRENSIQ is dosed as either:
It is important to use STRENSIQ as described in the Patient Prescribing Information and Instructions for Use, or as instructed by your doctor, nurse, and/or pharmacist.
Some people with hypophosphatasia (HPP) may feel like the condition takes away their independence.
Self-injecting STRENSIQ can take back some of this lost independence. Controlling injections can be empowering for some people, but it can also seem like a scary step to take. To prepare for self-injections, consider the following ideas:
If your doctor decides you or someone you care for is ready to self-inject STRENSIQ, do not hesitate to ask questions. It is important to ensure everyone involved is comfortable making this transition.
Establishing a routine can help someone adapt to remembering their injections. For example, some may prefer to inject in the morning before eating breakfast, while others may wish to inject at night before going to bed.
It may also be beneficial for a caregiver to monitor the first few self-injections. Having someone who is familiar with the injection process may relieve some anxiety about self-injecting.
Quinn and I have our STRENSIQ routine. He retrieves the vials while I prepare syringes and supplies. Depending upon the site, either he or I do the injection.”
Kara, Caregiver HPP STAR
Whether you are injecting STRENSIQ into yourself or someone you care for, it’s normal to feel anxious.
An important part of the process is for you to feel confident injecting STRENSIQ. If you need anything clarified about injection, don’t be afraid to ask questions or have your doctor review something more than once.
STRENSIQ can be injected under the skin of the stomach area, upper arms, upper legs, or buttocks.
STRENSIQ should not be injected into the buttocks for infants.
Choose a different area each time you inject to help avoid irritation at the injection site.
Do not inject STRENSIQ into skin that is red, hot, or swollen.
STRENSIQ may cause serious side effects, including serious allergic (hypersensitivity) reactions and skin thickening or pits at the injection site (lipodystrophy).
Speak with your nurse, doctor, and/or pharmacist for more information on where to inject STRENSIQ.
You may experience ISRs, which are painful, itchy, or swollen skin after injecting STRENSIQ® (asfotase alfa). A local skin injection-site reaction is one of the most common side effects of STRENSIQ.
In your first shipment of STRENSIQ, you will receive an injection starter kit. This kit provides an injection supply mat, injection site tracker and calendar, and other tools that will help establish a routine with STRENSIQ.
Read a complete guide on injecting STRENSIQ into yourself or someone you care for.
It’s normal to feel uneasy about fitting STRENSIQ into your routine. Check out more tips to help you feel confident as you begin and continue treatment.
IMPORTANT SAFETY INFORMATION INCLUDING BOXED WARNING
What is the most important information I should know about STRENSIQ?
Severe allergic (hypersensitivity) reactions have
occurred with STRENSIQ treatment and can be severe and life-threatening. Severe allergic
reactions have happened in some people within minutes
after receiving
STRENSIQ and more
than 1
year after starting
treatment with STRENSIQ.
What are the possible side effects of STRENSIQ?
STRENSIQ may cause serious side effects, including:
Severe allergic (hypersensitivity) reactions. Allergic
reactions are
common with STRENSIQ treatment and can be severe and life
threatening. Severe allergic reactions have happened in some people within
minutes after receiving STRENSIQ and more than 1 year after starting
treatment with
STRENSIQ.
Stop using STRENSIQ and go to the nearest hospital emergency room right away if you or your loved one have any of the signs and symptoms of a severe allergic reaction:
Call your doctor if you experience any of the following signs and symptoms of an allergic reaction: fever, headache, sweating, feeling irritable, chills, skin redness, skin rash or hives.
Skin thickening or pits at the injection site (lipodystrophy) has happened several months after using STRENSIQ.
Calcium buildup in the eyes and kidneys. People with HPP
are at increased risk for developing calcium build-up due to disease
and may be a side
effect of STRENSIQ, although it may also occur in untreated
patients. Your healthcare provider should check your eyes and kidneys
before
and during
treatment with STRENSIQ.
Immune-related effects. You may develop antibodies
during
treatment that may decrease how well STRENSIQ works. Tell your healthcare provider right away if you get worsening symptoms of HPP including
difficulty breathing or walking, feeling tired, bone pain, stiff joints, or loss of appetite.
The most common side effects of STRENSIQ include local skin injection-site reactions (skin redness, bruising, color change, pain, itching, swelling, and bumps).
These are not all the possible side effects of STRENSIQ. For more information, ask your healthcare provider or pharmacist.
Before using STRENSIQ, tell your healthcare provider about all
your medical conditions, including if
you:
Tell your healthcare provider about all the
medicines you
take,
including
prescription and over-the-counter medicines,
vitamins, and herbal
supplements.
There is a registry for people who use STRENSIQ. The purpose of this registry is to collect information about HPP and about what happens when you use STRENSIQ for a long time. For more information about this registry, talk with your healthcare provider or go to www.hppregistry.com.
Call your healthcare provider for medical advice about
side effects. To report SUSPECTED SIDE EFFECTS, contact Alexion
Pharmaceuticals, Inc. at
1-844-259-6783 or FDA at
1- 800-FDA-1088
or
www.fda.gov/
medwatch
Please see the full Prescribing Information,
and Patient Information for STRENSIQ
(asfotase
alfa), including Boxed
WARNING regarding severe allergic
(hypersensitivity) reaction
INDICATION
What is STRENSIQ?
STRENSIQ® (asfotase alfa) is a prescription medicine
used to
treat people
with perinatal, infantile, and juvenile onset
hypophosphatasia (HPP).
IMPORTANT SAFETY INFORMATION INCLUDING BOXED WARNING
What is the most important information I should know about STRENSIQ?
Severe allergic (hypersensitivity) reactions have
occurred with STRENSIQ treatment and can be severe and life-threatening. Severe allergic
reactions have happened in some people within minutes
after receiving
STRENSIQ and more
than 1
year after starting
treatment with STRENSIQ.
What are the possible side effects of STRENSIQ?
STRENSIQ may cause serious side effects, including:
Severe allergic (hypersensitivity) reactions. Allergic
reactions are
common with STRENSIQ treatment and can be severe and life
threatening. Severe allergic reactions have happened in some people within
minutes after receiving STRENSIQ and more than 1 year after starting
treatment with
STRENSIQ.
Stop using STRENSIQ and go to the nearest hospital emergency room right away if you or your loved one have any of the signs and symptoms of a severe allergic reaction:
Call your doctor if you experience any of the following signs and symptoms of an allergic reaction: fever, headache, sweating, feeling irritable, chills, skin redness, skin rash or hives.
Skin thickening or pits at the injection site (lipodystrophy) has happened several months after using STRENSIQ.
Calcium buildup in the eyes and kidneys. People with HPP
are at increased risk for developing calcium build-up due to disease
and may be a side
effect of STRENSIQ, although it may also occur in untreated
patients. Your healthcare provider should check your eyes and kidneys
before
and during
treatment with STRENSIQ.
Immune-related effects. You may develop antibodies
during
treatment that may decrease how well STRENSIQ works. Tell your healthcare provider right away if you get worsening symptoms of HPP including
difficulty breathing or walking, feeling tired, bone pain, stiff joints, or loss of appetite.
The most common side effects of STRENSIQ include local skin injection-site reactions (skin redness, bruising, color change, pain, itching, swelling, and bumps).
These are not all the possible side effects of STRENSIQ. For more information, ask your healthcare provider or pharmacist.
Before using STRENSIQ, tell your healthcare provider about all
your medical conditions, including if
you:
Tell your healthcare provider about all the
medicines you
take,
including
prescription and over-the-counter medicines,
vitamins, and herbal
supplements.
There is a registry for people who use STRENSIQ. The purpose of this registry is to collect information about HPP and about what happens when you use STRENSIQ for a long time. For more information about this registry, talk with your healthcare provider or go to www.hppregistry.com.
Call your healthcare provider for medical advice about
side effects. To report SUSPECTED SIDE EFFECTS, contact Alexion
Pharmaceuticals, Inc. at
1-844-259-6783 or FDA at
1- 800-FDA-1088
or
www.fda.gov/
medwatch
Please see the full Prescribing Information,
and Patient Information for STRENSIQ
(asfotase
alfa), including Boxed
WARNING regarding severe allergic
(hypersensitivity) reaction
INDICATION
What is STRENSIQ?
STRENSIQ® (asfotase alfa) is a prescription medicine
used to
treat people
with perinatal, infantile, and juvenile onset
hypophosphatasia (HPP).